|
1
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cocquerelle C, Mascrez B, Hétuin D and
Bailleul B: Mis-splicing yields circular RNA molecules. FASEB J.
7:155–160. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzuki H and Tsukahara T: A view of
pre-mRNA splicing from RNase R resistant RNAs. Int J Mol Sci.
15:9331–9342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar :
|
|
5
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahmadov U, Bendikas MM, Ebbesen KK,
Sehested AM, Kjems J, Broholm H and Kristensen LS: Distinct
circular RNA expression profiles in pediatric ependymomas. Brain
Pathol. 31:387–392. 2021. View Article : Google Scholar :
|
|
7
|
Smid M, Wilting SM, Uhr K,
Rodríguez-González FG, de Weerd V, Prager-Van der Smissen WJC, van
der Vlugt-Daane M, van Galen A, Nik-Zainal S, Butler A, et al: The
circular RNome of primary breast cancer. Genome Res. 29:356–366.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang C, Tan S, Liu WR, Lei Q, Qiao W, Wu
Y, Liu X, Cheng W, Wei YQ, Peng Y and Li W: RNA-Seq profiling of
circular RNA in human lung adenocarcinoma and squamous cell
carcinoma. Mol Cancer. 18:1342019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 World Health Organization
classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oser MG, Niederst MJ, Sequist LV and
Engelman JA: Transformation from non-small-cell lung cancer to
small-cell lung cancer: Molecular drivers and cells of origin.
Lancet Oncol. 16:e165–e172. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ettinger DS, Wood DE, Aisner DL, Akerley
W, Bauman J, Chirieac LR, D'Amico TA, DeCamp MM, Dilling TJ,
Dobelbower M, et al: Non-small cell lung cancer, version 5.2017,
NCCN clinical practice guidelines in oncology. J Natl Compr Canc
Netw. 15:504–535. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schneider BJ, Ismaila N, Aerts J, Chiles
C, Daly ME, Detterbeck FC, Hearn JWD, Katz SI, Leighl NB, Levy B,
et al: Lung cancer surveillance after definitive curative-intent
therapy: ASCO guideline. J Clin Oncol. 38:753–766. 2020. View Article : Google Scholar
|
|
14
|
Kristensen LS, Jakobsen T, Hager H and
Kjems J: The emerging roles of circRNAs in cancer and oncology. Nat
Rev Clin Oncol. 19:188–206. 2022. View Article : Google Scholar
|
|
15
|
Chen LL: The expanding regulatory
mechanisms and cellular functions of circular RNAs. Nat Rev Mol
Cell Biol. 21:475–490. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Misir S, Wu N and Yang BB: Specific
expression and functions of circular RNAs. Cell Death Differ.
29:481–491. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen I, Chen CY and Chuang TJ: Biogenesis,
identification, and function of exonic circular RNAs. Wiley
Interdiscip Rev RNA. 6:563–579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kristensen LS, Andersen MS, Stagsted LVW,
Ebbesen KK, Hansen TB and Kjems J: The biogenesis, biology and
characterization of circular RNAs. Nat Rev Genet. 20:675–691. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang
W, Wang G, Wu P, Wang H, Jiang L, et al: Exosomal circRNAs:
Biogenesis, effect and application in human diseases. Mol Cancer.
18:1162019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang XY, Huang ZL, Huang J, Xu B, Huang
XY, Xu YH, Zhou J and Tang ZY: Exosomal circRNA-100338 promotes
hepatocellular carcinoma metastasis via enhancing invasiveness and
angiogenesis. J Exp Clin Cancer Res. 39:202020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang PF, Gao C, Huang XY, Lu JC, Guo XJ,
Shi GM, Cai JB and Ke AW: Cancer cell-derived exosomal circUHRF1
induces natural killer cell exhaustion and may cause resistance to
anti-PD1 therapy in hepatocellular carcinoma. Mol Cancer.
19:1102020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang C, Wu S, Mou Z, Zhou Q, Dai X, Ou Y,
Chen X, Chen Y, Xu C, Hu Y, et al: Exosome-derived circTRPS1
promotes malignant phenotype and CD8+ T cell exhaustion in bladder
cancer microenvironments. Mol Ther. 30:1054–1070. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fanale D, Taverna S, Russo A and Bazan V:
Circular RNA in exosomes. Adv Exp Med Biol. 1087:109–117. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li C, Ni YQ, Xu H, Xiang QY, Zhao Y, Zhan
JK, He JY, Li S and Liu YS: Roles and mechanisms of exosomal
non-coding RNAs in human health and diseases. Signal Transduct
Target Ther. 6:3832021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer Lett. 365:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL
and Yang L: Complementary sequence-mediated exon circularization.
Cell. 159:134–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fei T, Chen Y, Xiao T, Li W, Cato L, Zhang
P, Cotter MB, Bowden M, Lis RT, Zhao SG, et al: Genome-wide CRISPR
screen identifies HNRNPL as a prostate cancer dependency regulating
RNA splicing. Proc Natl Acad Sci USA. 114:E5207–E5215. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Conn SJ, Pillman KA, Toubia J, Conn VM,
Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA and
Goodall GJ: The RNA binding protein quaking regulates formation of
circRNAs. Cell. 160:1125–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Barrett SP, Wang PL and Salzman J:
Circular RNA biogenesis can proceed through an exon-containing
lariat precursor. Elife. 4:e075402015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eger N, Schoppe L, Schuster S, Laufs U and
Boeckel JN: Circular RNA splicing. Adv Exp Med Biol. 1087:41–52.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin
QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long
noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maass PG, Glažar P, Memczak S, Dittmar G,
Hollfinger I, Schreyer L, Sauer AV, Toka O, Aiuti A, Luft FC and
Rajewsky N: A map of human circular RNAs in clinically relevant
tissues. J Mol Med (Berl). 95:1179–1189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu D and Xu AD: Mini review: Circular RNAs
as potential clinical biomarkers for disorders in the central
nervous system. Front Genet. 7:532016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Abe N, Matsumoto K, Nishihara M, Nakano Y,
Shibata A, Maruyama H, Shuto S, Matsuda A, Yoshida M, Ito Y and Abe
H: Rolling circle translation of circular RNA in living human
cells. Sci Rep. 5:164352015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Legnini I, Di Timoteo G, Rossi F, Morlando
M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade
M, et al: Circ-ZNF609 is a circular RNA that can be translated and
functions in myogenesis. Mol Cell. 66:22–37.e9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pamudurti NR, Patop IL, Krishnamoorthy A,
Bartok O, Maya R, Lerner N, Ashwall-Fluss R, Konakondla JVV, Beatus
T and Kadener S: circMbl functions in cis and in trans to regulate
gene expression and physiology in a tissue-specific fashion. Cell
Rep. 39:1107402022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang Y, Fan X, Mao M, Song X, Wu P, Zhang
Y, Jin Y, Yang Y, Chen LL, Wang Y, et al: Extensive translation of
circular RNAs driven by N6-methyladenosine. Cell Res.
27:626–641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Du WW, Xu J, Yang W, Wu N, Li F, Zhou L,
Wang S, Li X, He AT, Du KY, et al: A neuroligin isoform translated
by circNlgn contributes to cardiac remodeling. Circ Res.
129:568–582. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pamudurti NR, Bartok O, Jens M,
Ashwal-Fluss R, Stottmeister C, Ruhe L, Hanan M, Wyler E,
Perez-Hernandez D, Ramberger E, et al: Translation of CircRNAs. Mol
Cell. 66:9–21.e7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao
F, Huang N, Yang X, Zhao K, Zhou H, et al: Novel role of FBXW7
circular RNA in repressing glioma tumorigenesis. J Natl Cancer
Inst. 110:304–315. 2018. View Article : Google Scholar :
|
|
46
|
Gao X, Xia X, Li F, Zhang M, Zhou H, Wu X,
Zhong J, Zhao Z, Zhao K, Liu D, et al: Circular RNA-encoded
oncogenic E-cadherin variant promotes glioblastoma tumorigenicity
through activation of EGFR-STAT3 signalling. Nat Cell Biol.
23:278–291. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li Y, Chen B, Zhao J, Li Q, Chen S, Guo T,
Li Y, Lai H, Chen Z, Meng Z, et al: HNRNPL circularizes ARHGAP35 to
produce an oncogenic protein. Adv Sci (Weinh). 8:20017012021.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jiang T, Xia Y, Lv J, Li B, Li Y, Wang S,
Xuan Z, Xie L, Qiu S, He Z, et al: A novel protein encoded by
circMAPK1 inhibits progression of gastric cancer by suppressing
activation of MAPK signaling. Mol Cancer. 20:662021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang M, Zhao K, Xu X, Yang Y, Yan S, Wei
P, Liu H, Xu J, Xiao F, Zhou H, et al: A peptide encoded by
circular form of LINC-PINT suppresses oncogenic transcriptional
elongation in glioblastoma. Nat Commun. 9:44752018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang M, Huang N, Yang X, Luo J, Yan S,
Xiao F, Chen W, Gao X, Zhao K, Zhou H, et al: A novel protein
encoded by the circular form of the SHPRH gene suppresses glioma
tumorigenesis. Oncogene. 37:1805–1814. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ghafouri-Fard S, Dinger ME, Maleki P,
Taheri M and Hajiesmaeili M: Emerging role of circular RNAs in the
pathobiology of lung cancer. Biomed Pharmacother. 141:1118052021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jin M, Shi C, Yang C, Liu J and Huang G:
Upregulated circRNA ARHGAP10 predicts an unfavorable prognosis in
NSCLC through regulation of the miR-150-5p/GLUT-1 axis. Mol Ther
Nucleic Acids. 18:219–231. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wei S, Zheng Y, Jiang Y, Li X, Geng J,
Shen Y, Li Q, Wang X, Zhao C, Chen Y, et al: The circRNA circPTPRA
suppresses epithelial-mesenchymal transitioning and metastasis of
NSCLC cells by sponging miR-96-5p. EBioMedicine. 44:182–193. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fu Y, Huang L, Tang H and Huang R:
hsa_circRNA_012515 Is Highly expressed in NSCLC patients and
affects its prognosis. Cancer Manag Res. 12:1877–1886. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhou J, Zhang S, Chen Z, He Z, Xu Y and Li
Z: CircRNA-ENO1 promoted glycolysis and tumor progression in lung
adenocarcinoma through upregulating its host gene ENO1. Cell Death
Dis. 10:8852019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan
Y, Kong X, Bu J, Liu M and Xu S: circRNA-002178 act as a ceRNA to
promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis.
11:322020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang Z, Pei H, Liang H, Zhang Q, Wei L,
Shi D, Chen Y and Zhang J: Construction and analysis of a
circRNA-Mediated ceRNA network in lung adenocarcinoma. Onco Targets
Ther. 14:3659–3669. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yao Y, Hua Q and Zhou Y: CircRNA
has_circ_0006427 suppresses the progression of lung adenocarcinoma
by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin
signaling pathway. Biochem Biophys Res Commun. 508:37–45. 2019.
View Article : Google Scholar
|
|
60
|
Wang L, Liang Y, Mao Q, Xia W, Chen B,
Shen H, Xu L, Jiang F and Dong G: Circular RNA circCRIM1 inhibits
invasion and metastasis in lung adenocarcinoma through the microRNA
(miR)-182/miR-93-leukemia inhibitory factor receptor pathway.
Cancer Sci. 110:2960–2972. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Andersen MH, Becker JC and Straten PT:
Regulators of apoptosis: Suitable targets for immune therapy of
cancer. Nat Rev Drug Discov. 4:399–409. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kroemer G and Pouyssegur J: Tumor cell
metabolism: Cancer's Achilles' heel. Cancer Cell. 13:472–482. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Teixeira JC, de Filippo C, Weihmann A,
Meneu JR, Racimo F, Dannemann M, Nickel B, Fischer A, Halbwax M,
Andre C, et al: Long-term balancing selection in LAD1 maintains a
missense trans-species polymorphism in humans, chimpanzees, and
bonobos. Mol Biol Evol. 32:1186–1196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Roth L, Srivastava S, Lindzen M, Sas-Chen
A, Sheffer M, Lauriola M, Enuka Y, Noronha A, Mancini M, Lavi S, et
al: SILAC identifies LAD1 as a filamin-binding regulator of actin
dynamics in response to EGF and a marker of aggressive breast
tumors. Sci Signal. 11:eaan09492018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang Y: circ-ANXA7 facilitates lung
adenocarcinoma progression via miR-331/LAD1 axis. Cancer Cell Int.
21:852021. View Article : Google Scholar
|
|
66
|
Sun Z: Circular RNA hsa_circ_0001588
promotes the malignant progression of lung adenocarcinoma by
modulating miR-524-3p/NACC1 signaling. Life Sci. 259:1181572020.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhang S, Xia W, Dong G, Xu W, Li M and Xu
L: Cyclic RNA molecule circ_0007766 promotes the proliferation of
lung adenocarcinoma cells by up-regulating the expression of Cyclin
D1/CyclinE1/CDK4. Zhongguo Fei Ai Za Zhi. 22:271–279. 2019.In
Chinese. PubMed/NCBI
|
|
68
|
Jiang W, Zhang C, Kang Y, Li G, Feng Y and
Ma H: The roles and mechanisms of the circular RNA circ_104640 in
early-stage lung adenocarcinoma: A potential diagnostic and
therapeutic target. Ann Transl Med. 9:1382021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kahn M: Wnt signaling in stem cells and
cancer stem cells: A tale of two coactivators. Prog Mol Biol Transl
Sci. 153:209–244. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li O, Kang J, Zhang JJ, Wang J, Hu LW, Li
L, Sun YY, Bai Y, Wei QQ, Yan YP and Yi X: Circle RNA FOXP1
promotes cell proliferation in lung cancer by regulating
miR-185-5p/Wnt1 signaling pathway. Eur Rev Med Pharmacol Sci.
24:6767–6778. 2020.PubMed/NCBI
|
|
72
|
Foster R, Hu KQ, Lu Y, Nolan KM, Thissen J
and Settleman J: Identification of a novel human Rho protein with
unusual properties: GTPase deficiency and in vivo farnesylation.
Mol Cell Biol. 16:2689–2699. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yang X, Wang T, Lin X, Yue X, Wang Q, Wang
G, Fu Q, Ai X, Chiang DY, Miyake CY, et al: Genetic deletion of
Rnd3/RhoE results in mouse heart calcium leakage through
upregulation of protein kinase A signaling. Circ Res. 116:e1–e10.
2015. View Article : Google Scholar :
|
|
74
|
Jiang W, He Y, Ma Z, Zhang Y, Zhang C,
Zheng N and Tang X: hsa_circ_0008234 inhibits the progression of
lung adenocarcinoma by sponging miR-574-5p. Cell Death Discov.
7:1232021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yu C, Tian F, Liu J, Su M, Wu M, Zhu X and
Qian W: Circular RNA cMras inhibits lung adenocarcinoma progression
via modulating miR-567/PTPRG regulatory pathway. Cell Prolif.
52:e126102019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Dong Y, Qiu T, Xuan Y, Liu A, Sun X, Huang
Z, Su W, Du W, Yun T, Wo Y, et al: circFBXW7 attenuates malignant
progression in lung adenocarcinoma by sponging miR-942-5p. Transl
Lung Cancer Res. 10:1457–1473. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Eccles SA and Welch DR: Metastasis: Recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yuan DF, Wang HR, Wang ZF, Liang GH, Xing
WQ and Qin JJ: CircRNA CircZMYM4 inhibits the growth and metastasis
of lung adenocarcinoma via the miR-587/ODAM pathway. Biochem
Biophys Res Commun. 580:100–106. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kosfeld A, Brand F, Weiss AC, Kreuzer M,
Goerk M, Martens H, Schubert S, Schäfer AK, Riehmer V, Hennies I,
et al: Mutations in the leukemia inhibitory factor receptor (LIFR)
gene and Lifr deficiency cause urinary tract malformations. Hum Mol
Genet. 26:1716–1731. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Luo Q, Wang C, Jin G, Gu D, Wang N, Song
J, Jin H, Hu F, Zhang Y, Ge T, et al: LIFR functions as a
metastasis suppressor in hepatocellular carcinoma by negatively
regulating phosphoinositide 3-kinase/AKT pathway. Carcinogenesis.
36:1201–1212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yu Z, Zhu X, Li Y, Liang M, Liu M, Liu Z,
Qin L, Wu X, Du K, Liu L, et al: Circ-HMGA2 (hsa_circ_0027446)
promotes the metastasis and epithelial-mesenchymal transition of
lung adenocarcinoma cells through the miR-1236-3p/ZEB1 axis. Cell
Death Dis. 12:3132021. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Liang Y, Wang H, Chen B, Mao Q, Xia W,
Zhang T, Song X, Zhang Z, Xu L, Dong G and Jiang F: circDCUN1D4
suppresses tumor metastasis and glycolysis in lung adenocarcinoma
by stabilizing TXNIP expression. Mol Ther Nucleic Acids.
23:355–368. 2020. View Article : Google Scholar
|
|
83
|
Huang Q, Guo H, Wang S, Ma Y, Chen H, Li
H, Li J, Li X, Yang F, Qiu M, et al: A novel circular RNA,
circXPO1, promotes lung adenocarcinoma progression by interacting
with IGF2BP1. Cell Death Dis. 11:10312020. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Lv X, Huang H, Feng H and Wei Z: Circ-MMP2
(circ-0039411) induced by FOXM1 promotes the proliferation and
migration of lung adenocarcinoma cells in vitro and in vivo. Cell
Death Dis. 11:4262020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Xu J, Shu Y, Xu T, Zhu W, Qiu T, Li J,
Zhang M, Xu J, Guo R, Lu K, et al: Microarray expression profiling
and bioinformatics analysis of circular RNA expression in lung
squamous cell carcinoma. Am J Transl Res. 10:771–783.
2018.PubMed/NCBI
|
|
86
|
Cheng Z, Yu C, Cui S, Wang H, Jin H, Wang
C, Li B, Qin M, Yang C, He J, et al: circTP63 functions as a ceRNA
to promote lung squamous cell carcinoma progression by upregulating
FOXM1. Nat Commun. 10:32002019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhang W, Shi J, Cheng C and Wang H:
CircTIMELESS regulates the proliferation and invasion of lung
squamous cell carcinoma cells via the miR-136-5p/ROCK1 axis. J Cell
Physiol. 235:5962–5971. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Xiao M, Cui S, Zhang L, Yu T, Zhang G, Li
L, Cai Y, Jin C, Yang J, Wu S, et al: Benzo[a]pyrene diol
epoxide-induced transformed cells identify the significance of
hsa_circ_0051488, a ERCC1-derived circular RNA in pulmonary
squamous cell carcinoma. Mol Carcinog. 60:684–701. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Sabari JK, Lok BH, Laird JH, Poirier JT
and Rudin CM: Unravelling the biology of SCLC: Implications for
therapy. Nat Rev Clin Oncol. 14:549–561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhang C, Zhang B, Yuan B, Chen C, Zhou Y,
Zhang Y, Sheng Z, Sun N and Wu X: RNA-Seq profiling of circular
RNAs in human small cell lung cancer. Epigenomics. 12:685–700.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Yang X, Tao L, Xu Y, Li S, Yang W, Wang L
and Zhu J: CircMYC promotes proliferation, migration, invasion and
inhibits apoptosis of small cell lung cancer by targeting
miR-145/matrix metallopeptidase 2 axis. Bioengineered.
13:10552–10563. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Li L, Li W, Chen N, Zhao H, Xu G, Zhao Y,
Pan X, Zhang X, Zhou L, Yu D, et al: FLI1 exonic circular RNAs as a
novel oncogenic driver to promote tumor metastasis in small cell
lung cancer. Clin Cancer Res. 25:1302–1317. 2019. View Article : Google Scholar
|
|
93
|
Miller KD, Nogueira L, Mariotto AB,
Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL and Siegel
RL: Cancer treatment and survivorship statistics, 2019. CA Cancer J
Clin. 69:363–385. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Joseph NA, Chiou SH, Lung Z, Yang CL, Lin
TY, Chang HW, Sun HS, Gupta SK, Yen L, Wang SD and Chow KC: The
role of HGF-MET pathway and CCDC66 cirRNA expression in EGFR
resistance and epithelial-to-mesenchymal transition of lung
adenocarcinoma cells. J Hematol Oncol. 11:742018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Gerber DE and Schiller JH: Maintenance
chemotherapy for advanced non-small-cell lung cancer: New life for
an old idea. J Clin Oncol. 31:1009–1020. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Zhou Y, Zheng X, Xu B, Chen L, Wang Q,
Deng H and Jiang J: Circular RNA hsa_circ_0004015 regulates the
proliferation, invasion, and TKI drug resistance of non-small cell
lung cancer by miR-1183/PDPK1 signaling pathway. Biochem Biophys
Res Commun. 508:527–535. 2019. View Article : Google Scholar
|
|
97
|
Feng B, Zhou H, Wang T, Lin X, Lai Y, Chu
X and Wang R: Insights into circRNAs: Functional roles in lung
cancer management and the potential mechanisms. Front Cell Dev
Biol. 9:6369132021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group: Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Siddik ZH: Cisplatin: Mode of cytotoxic
action and molecular basis of resistance. Oncogene. 22:7265–7279.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Wang Y, Wu Y and Xie S: CircPTK2 inhibits
cell cisplatin (CDDP) resistance by targeting miR-942/TRIM16 axis
in non-small cell lung cancer (NSCLC). Bioengineered. 13:3651–3664.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Shi Q, Ji T, Ma Z, Tan Q and Liang J:
Serum exosomes-based biomarker circ_0008928 regulates cisplatin
sensitivity, tumor progression, and glycolysis metabolism by
miR-488/HK2 axis in cisplatin-resistant nonsmall cell lung
carcinoma. Cancer Biother Radiopharm. Mar 3–2021.Epub ahead of
print.
|
|
102
|
Li X, Yang B, Ren H, Xiao T, Zhang L, Li
L, Li M, Wang X, Zhou H and Zhang W: Hsa_circ_0002483 inhibited the
progression and enhanced the Taxol sensitivity of non-small cell
lung cancer by targeting miR-182-5p. Cell Death Dis. 10:9532019.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Li J, Fan R and Xiao H: Circ_ZFR
contributes to the paclitaxel resistance and progression of
non-small cell lung cancer by upregulating KPNA4 through sponging
miR-195-5p. Cancer Cell Int. 21:152021. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Xu J, Ni L, Zhao F, Dai X, Tao J, Pan J,
Shi A, Shen Z, Su C and Zhang Y: Overexpression of hsa_circ_0002874
promotes resistance of non-small cell lung cancer to paclitaxel by
modulating miR-1273f/MDM2/p53 pathway. Aging (Albany NY).
13:5986–6009. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Joshi M, Liu X and Belani CP: Taxanes,
past, present, and future impact on non-small cell lung cancer.
Anticancer Drugs. 25:571–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Chen J, Liu X, Xu Y, Zhang K, Huang J, Pan
B, Chen D, Cui S, Song H, Wang R, et al: TFAP2C-activated MALAT1
modulates the chemoresistance of docetaxel-resistant lung
adenocarcinoma cells. Mol Ther Nucleic Acids. 14:567–582. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Yu W, Peng W, Sha H and Li J:
Hsa_circ_0003998 promotes chemoresistance via modulation of miR-326
in lung adenocarcinoma cells. Oncol Res. 27:623–628. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Zheng S, Wang C, Yan H and Du Y: Blocking
hsa_circ_0074027 suppressed non-small cell lung cancer
chemoresistance via the miR-379-5p/IGF1 axis. Bioengineered.
12:8347–8357. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Mao Y and Xu R: Circular RNA CDR1-AS
contributes to pemetrexed and cisplatin chemoresistance through
EGFR/PI3K signaling pathway in lung adenocarcinoma. Biomed
Pharmacother. 123:1097712020. View Article : Google Scholar
|
|
110
|
Zheng F and Xu R: CircPVT1 contributes to
chemotherapy resistance of lung adenocarcinoma through
miR-145-5p/ABCC1 axis. Biomed Pharmacother. 124:1098282020.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Mirski SE, Gerlach JH and Cole SP:
Multidrug resistance in a human small cell lung cancer cell line
selected in adriamycin. Cancer Res. 47:2594–2598. 1987.PubMed/NCBI
|
|
112
|
Desai A and Adjei AA: FGFR signaling as a
target for lung cancer therapy. J Thorac Oncol. 11:9–20. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Yang B, Teng F, Chang L, Wang J, Liu DL,
Cui YS and Li GH: Tumor-derived exosomal circRNA_102481 contributes
to EGFR-TKIs resistance via the miR-30a-5p/ROR1 axis in non-small
cell lung cancer. Aging (Albany NY). 13:13264–13286. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Liu S, Jiang Z, Xiao P, Li X, Chen Y, Tang
H, Chai Y, Liu Y, Zhu Z, Xie Q, et al: Hsa_circ_0005576 promotes
osimertinib resistance through the miR-512-5p/IGF1R axis in lung
adenocarcinoma cells. Cancer Sci. 113:79–90. 2022. View Article : Google Scholar
|
|
115
|
Dai C, Ma Z, Si J, An G, Zhang W, Li S and
Ma Y: Hsa_ circ_0007312 promotes third-generation epidermal growth
factor receptor-tyrosine kinase inhibitor resistance through
pyroptosis and apoptosis via the MiR-764/MAPK1 axis in lung
adenocarcinoma cells. J Cancer. 13:2798–2809. 2022. View Article : Google Scholar :
|
|
116
|
Zhang CC, Li Y, Feng XZ and Li DB:
Circular RNA circ_0001287 inhibits the proliferation, metastasis,
and radiosensitivity of non-small cell lung cancer cells by
sponging microRNA miR-21 and up-regulating phosphatase and tensin
homolog expression. Bioengineered. 12:414–425. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Jin Y, Su Z, Sheng H, Li K, Yang B and Li
S: Circ_0086720 knockdown strengthens the radiosensitivity of
non-small cell lung cancer via mediating the miR-375/SPIN1 axis.
Neoplasma. 68:96–107. 2021. View Article : Google Scholar
|
|
118
|
Li YH, Xu CL, He CJ, Pu HH, Liu JL and
Wang Y: circ-MTDH.4/miR-630/AEG-1 axis participates in the
regulation of proliferation, migration, invasion, chemoresistance,
and radioresistance of NSCLC. Mol Carcinog. 59:141–153. 2020.
View Article : Google Scholar
|
|
119
|
Zhang T, Wu DM, Luo PW, Liu T, Han R, Deng
SH, He M, Zhao YY and Xu Y: CircNEIL3 mediates pyroptosis to
influence lung adenocarcinoma radiotherapy by upregulating PIF1
through miR-1184 inhibition. Cell Death Dis. 13:1672022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Liu B, Li H, Liu X, Li F, Chen W, Kuang Y,
Zhao X, Li L, Yu B, Jin X and Li Q: CircZNF208 enhances the
sensitivity to X-rays instead of carbon-ions through the
miR-7-5p/SNCA signal axis in non-small-cell lung cancer cells. Cell
Signal. 84:1100122021. View Article : Google Scholar
|
|
121
|
Horn L, Spigel DR, Vokes EE, Holgado E,
Ready N, Steins M, Poddubskaya E, Borghaei H, Felip E, Paz-Ares L,
et al: Nivolumab versus docetaxel in previously treated patients
with advanced non-small-cell lung cancer: Two-year outcomes from
two randomized, open-label, phase III trials (CheckMate 017 and
CheckMate 057). J Clin Oncol. 35:3924–3933. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Chen SW, Zhu SQ, Pei X, Qiu BQ, Xiong D,
Long X, Lin K, Lu F, Xu JJ and Wu YB: Cancer cell-derived exosomal
circUSP7 induces CD8+ T cell dysfunction and anti-PD1
resistance by regulating the miR-934/SHP2 axis in NSCLC. Mol
Cancer. 20:1442021. View Article : Google Scholar
|
|
123
|
Liu Z, Wang T, She Y, Wu K, Gu S, Li L,
Dong C, Chen C and Zhou Y: N6-methyladenosine-modified
circIGF2BP3 inhibits CD8+ T-cell responses to facilitate
tumor immune evasion by promoting the deubiquitination of PD-L1 in
non-small cell lung cancer. Mol Cancer. 20:1052021. View Article : Google Scholar
|
|
124
|
Kumar S, Zeng Z, Bagati A, Tay RE, Sanz
LA, Hartono SR, Ito Y, Abderazzaq F, Hatchi E, Jiang P, et al:
CARM1 inhibition enables immunotherapy of resistant tumors by dual
action on tumor cells and T cells. Cancer Discov. 11:2050–2071.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zhang LX, Gao J, Long X, Zhang PF, Yang X,
Zhu SQ, Pei X, Qiu BQ, Chen SW, Lu F, et al: The circular RNA
circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung
adenocarcinomas and squamous cell carcinomas via the
miR-181a-5p/CARM1 axis. Mol Cancer. 21:1102022. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Memczak S, Papavasileiou P, Peters O and
Rajewsky N: Identification and characterization of circular RNAs as
a new class of putative biomarkers in human blood. PLoS One.
10:e01412142015. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Ye D, Gong M, Deng Y, Fang S, Cao Y, Xiang
Y and Shen Z: Roles and clinical application of exosomal circRNAs
in the diagnosis and treatment of malignant tumors. J Transl Med.
20:1612022. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Chen HH, Zhang TN, Wu QJ, Huang XM and
Zhao YH: Circular RNAs in lung cancer: Recent advances and future
perspectives. Front Oncol. 11:6642902021. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Zhang N, Nan A, Chen L, Li X, Jia Y, Qiu
M, Dai X, Zhou H, Zhu J, Zhang H and Jiang Y: Circular RNA
circSATB2 promotes progression of non-small cell lung cancer cells.
Mol Cancer. 19:1012020. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Yang F, Ma C, Qiu J, Feng X and Yang K:
Identification of circRNA_001846 as putative non-small cell lung
cancer biomarker. Bioengineered. 12:8690–8697. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Best MG, Sol N, In 't Veld SGJG, Vancura
A, Muller M, Niemeijer AN, Fejes AV, Tjon Kon Fat LA, Huis In 't
Veld AE, Leurs C, et al: Swarm intelligence-enhanced detection of
non-small-cell lung cancer using tumor-educated platelets. Cancer
Cell. 32:238–252.e9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
D'Ambrosi S, Visser A, Antunes-Ferreira M,
Poutsma A, Giannoukakos S, Sol N, Sabrkhany S, Bahce I, Kuijpers
MJE, Oude Egbrink MGA, et al: The analysis of platelet-derived
circRNA repertoire as potential diagnostic biomarker for non-small
cell lung cancer. Cancers (Basel). 13:46442021. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Hu ZQ, Zhou SL, Li J, Zhou ZJ, Wang PC,
Xin HY, Mao L, Luo CB, Yu SY, Huang XW, et al: Circular RNA
sequencing identifies CircASAP1 as a key regulator in
hepatocellular carcinoma metastasis. Hepatology. 72:906–922. 2020.
View Article : Google Scholar
|
|
134
|
Lu GJ, Cui J, Qian Q, Hou ZB, Xie HY, Hu
W, Hao KK, Xia N and Zhang Y: Overexpression of hsa_circ_0001715 is
a potential diagnostic and prognostic biomarker in lung
adenocarcinoma. Onco Targets Ther. 13:10775–10783. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Zhang ZY, Gao XH, Ma MY, Zhao CL, Zhang YL
and Guo SS: CircRNA_101237 promotes NSCLC progression via the
miRNA-490-3p/MAPK1 axis. Sci Rep. 10:90242020. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Hong Y, Si J, Xiao B, Xiong Y, Dai C, Yang
Y, Li S and Ma Y: circ_0000567/miR-421/TMEM100 axis promotes the
migration and invasion of lung adenocarcinoma and is associated
with prognosis. J Cancer. 13:1540–1552. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Luo YH, Yang YP, Chien CS, Yarmishyn AA,
Ishola AA, Chien Y, Chen YM, Huang TW, Lee KY, Huang WC, et al:
Plasma level of circular RNA hsa_circ_0000190 correlates with tumor
progression and poor treatment response in advanced lung cancers.
Cancers (Basel). 12:17402020. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Feng D, Xu Y, Hu J, Zhang S, Li M and Xu
L: A novel circular RNA, hsa-circ-0000211, promotes lung
adenocarcinoma migration and invasion through sponging of
hsa-miR-622 and modulating HIF1-α expression. Biochem Biophys Res
Commun. 521:395–401. 2020. View Article : Google Scholar
|
|
139
|
Xu Y, Yu J, Huang Z, Fu B, Tao Y, Qi X,
Mou Y, Hu Y, Wang Y, Cao Y, et al: Circular RNA hsa_circ_0000326
acts as a miR-338-3p sponge to facilitate lung adenocarcinoma
progression. J Exp Clin Cancer Res. 39:572020. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Wang L, Li M and Lian R: Depleting
hsa_circ_0000567 suppresses acquired gefitinib resistance and
proliferation of lung adenocarcinoma cells through regulating the
miR-377-3p/ZFX axis: An in vitro and in vivo study. Histol
Histopathol. 37:637–654. 2022.PubMed/NCBI
|
|
141
|
Zuo Y, Shen W, Wang C, Niu N and Pu J:
Circular RNA Circ-ZNF609 promotes lung adenocarcinoma proliferation
by modulating miR-1224-3p/ETV1 signaling. Cancer Manag Res.
12:2471–2479. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Huang C, Yue W, Li L, Li S, Gao C, Si L,
Qi L, Cheng C, Lu M, Chen G, et al: Circular RNA hsa-circ-000881
suppresses the progression of lung adenocarcinoma in vitro via a
miR-665/PRICKLE2 axis. Ann Transl Med. 9:4982021. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Mao Y and He JX, Zhu M, Dong YQ and He JX:
Circ0001320 inhibits lung cancer cell growth and invasion by
regulating TNFAIP1 and TPM1 expression through sponging miR-558.
Hum Cell. 34:468–477. 2021. View Article : Google Scholar
|
|
144
|
Shen HY, Shi LX, Wang L, Fang LP, Xu W, Xu
JQ, Fan BQ and Fan WF: Hsa_circ_0001361 facilitates the progress of
lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis. J
Transl Med. 19:3892021. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Lu T, Qiu T, Han B, Wang Y, Sun X, Qin Y,
Liu A, Ge N and Jiao W: Circular RNA circCSNK1G3 induces HOXA10
signaling and promotes the growth and metastasis of lung
adenocarcinoma cells through hsa-miR-143-3p sponging. Cell Oncol
(Dordr). 44:297–310. 2021. View Article : Google Scholar
|
|
146
|
Zhou H, Huang X, Yang X, Jiang F, Shao F,
Shi W, Huang K, Pan J, Zhang Y, Chen J and Wang Y: CircRAPGEF5
promotes the proliferation and metastasis of lung adenocarcinoma
through the miR-1236-3p/ZEB1 axis and serves as a potential
biomarker. Int J Biol Sci. 18:2116–2131. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Cao L, Zhou X, Ding X and Gao D: Knockdown
of circ-PVT1 inhibits the progression of lung adenocarcinoma and
enhances the sensitivity to cisplatin via the miR-429/FOXK1
signaling axis. Mol Med Rep. 24:6842021. View Article : Google Scholar :
|
|
148
|
Yao Y, Hua Q, Zhou Y and Shen H: CircRNA
has_circ_0001946 promotes cell growth in lung adenocarcinoma by
regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin
signaling pathway. Biomed Pharmacother. 111:1367–1375. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zhu L, Guo T, Chen W, Lin Z, Ye M and Pan
X: CircMMD_007 promotes oncogenic effects in the progression of
lung adenocarcinoma through microRNA-197-3p/protein tyrosine
phosphatase non-receptor type 9 axis. Bioengineered. 13:4991–5004.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Wan J, Ding G, Zhou M, Ling X and Rao Z:
Circular RNA hsa_circ_0002483 promotes growth and invasion of lung
adenocarcinoma by sponging miR-125a-3p. Cancer Cell Int.
21:5332021. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Li H and Liu L: Zinc moderates circular
RNA CircFOXP1 expression in order to regulate ferroptosis during
lung adenocarcinoma. Chem Biol Interact. 352:1097602022. View Article : Google Scholar
|
|
152
|
Wang HL, Wang HR, Liang Y, Hu AN, Enguita
FJ, Zhou XG and Dong J: Hsa_circ_0006571 promotes spinal metastasis
through sponging microRNA-138 to regulate sirtuin 1 expression in
lung adenocarcinoma. Transl Lung Cancer Res. 9:2411–2427. 2020.
View Article : Google Scholar
|
|
153
|
Yang Y, Fan X, Nie Y, Liu D, Zhu D, Wu K,
Zhang Y, Li W, Tian X, Wang H and Fan Y: CircTUBGCP3 facilitates
the tumorigenesis of lung adenocarcinoma by sponging miR-885-3p.
Cancer Cell Int. 21:6512021. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Ma D, Liu H, Qin Y, Li D, Cui Y, Li L, He
J, Chen Y and Zhou X: Circ_0007142/miR-186/FOXK1 axis promoted lung
adenocarcinoma progression. Am J Transl Res. 12:4728–4738.
2020.PubMed/NCBI
|
|
155
|
Zhang B, Chen M, Jiang N, Shi K and Qian
R: A regulatory circuit of circ-MTO1/miR-17/QKI-5 inhibits the
proliferation of lung adenocarcinoma. Cancer Biol Ther.
20:1127–1135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Chen M, Huang X, Li L, Huang M, Cai R and
Liao X: A regulatory axis of circ_0008193/miR-1180-3p/TRIM62
suppresses proliferation, migration, invasion, and Warburg effect
in lung adenocarcinoma cells under hypoxia. Med Sci Monit.
26:e9229002020.PubMed/NCBI
|
|
157
|
Wang M, Ma M, Yang Y, Li C, Wang Y, Sun X,
Wang M, Sun Y and Jiao W: Overexpression of hsa_circ_0008274
inhibited the progression of lung adenocarcinoma by regulating
HMGA2 via sponging miR-578. Thorac Cancer. 12:2258–2264. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Chen J, Xu S, Chen S, Zong Z, Han X, Zhao
Y and Shang H: CircPUM1 promotes the malignant behavior of lung
adenocarcinoma by regulating miR-326. Biochem Biophys Res Commun.
508:844–849. 2019. View Article : Google Scholar
|
|
159
|
Wang X, Zhu X, Zhang H, Wei S, Chen Y,
Chen Y, Wang F, Fan X, Han S and Wu G: Increased circular RNA
hsa_circ_0012673 acts as a sponge of miR-22 to promote lung
adenocarcinoma proliferation. Biochem Biophys Res Commun.
496:1069–1075. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Zhu X, Wang X, Wei S, Chen Y, Chen Y, Fan
X, Han S and Wu G: hsa_circ_0013958: A circular RNA and potential
novel biomarker for lung adenocarcinoma. FEBS J. 284:2170–2182.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Zan SJ, Zhao Y, Fang T and Chen K:
Expression of circular RNA hsa_circ_0014130 in lung adenocarcinoma
cell lines and its effect on proliferation and invasion of lung
adenocarcinoma cell line. Zhonghua Bing Li Xue Za Zhi. 48:934–939.
2019.In Chinese. PubMed/NCBI
|
|
162
|
Yao Y, Zhou Y and Hua Q: circRNA
hsa_circ_0018414 inhibits the progression of LUAD by sponging
miR-6807-3p and upregulating DKK1. Mol Ther Nucleic Acids.
23:783–796. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Ying X, Zhu J and Zhang Y: Circular RNA
circ-TSPAN4 promotes lung adenocarcinoma metastasis by upregulating
ZEB1 via sponging miR-665. Mol Genet Genomic Med. 7:e9912019.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Li X, Su S, Ye D, Yu Z, Lu W and Liu L:
Hsa_circ_0020850 promotes the malignant behaviors of lung
adenocarcinoma by regulating miR-326/BECN1 axis. World J Surg
Oncol. 20:132022. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Xin T, Li S, Zhang Y, Kamali X, Liu H and
Jia T: circRNA Hsa_circ_0020850 silence represses the development
of lung adenocarcinoma via regulating miR-195-5p/IRS2 axis. Cancer
Manag Res. 12:10679–10692. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Wu S, Li H, Lu C, Zhang F, Wang H, Lu X
and Zhang G: Aberrant expression of hsa_circ_0025036 in lung
adenocarcinoma and its potential roles in regulating cell
proliferation and apoptosis. Biol Chem. 399:1457–1467. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Liu M, Wang P, Sui X, Ding F, Liu L, Gao Z
and Cheng Z: Circular RNA circABCC4 regulates lung adenocarcinoma
progression via miR-3186-3p/TNRC6B axis. J Cell Biochem.
121:4226–4238. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Yang Y, Zhang Y, Ding X, Ren Y, Wei B, Lin
Z, Nie Y and Fan Y: Construction and analysis of the ceRNA network
hsa_circ_0031968/miR-3611/GCG in lung adenocarcinoma. Ann Transl
Med. 9:17572021. View Article : Google Scholar
|
|
169
|
Wang Y, Ren F, Sun D, Liu J, Liu B, He Y,
Pang S, Shi B, Zhou F, Yao L, et al: CircKEAP1 suppresses the
progression of lung adenocarcinoma via the miR-141-3p/KEAP1/NRF2
axis. Front Oncol. 11:6725862021. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Zhou Q and Sun Y: Circular RNA cMras
suppresses the progression of lung adenocarcinoma through
ABHD5/ATGL axis using NF-κB signaling pathway. Cancer Biother
Radiopharm. Aug 19–2020.Epub ahead of print.
|
|
171
|
Sui MH, Zhang WW, Geng DM and Sun DJ:
CircPRKCI regulates proliferation, migration and cycle of lung
adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D. Eur
Rev Med Pharmacol Sci. 25:1899–1909. 2021.PubMed/NCBI
|
|
172
|
Qiu M, Xia W, Chen R, Wang S, Xu Y, Ma Z,
Xu W, Zhang E, Wang J, Fang T, et al: The circular RNA circPRKCI
promotes tumor growth in lung adenocarcinoma. Cancer Res.
78:2839–2851. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Xu L, Ma Y, Zhang H, Lu QJ, Yang L, Jiang
GN and Liao WL: HMGA2 regulates circular RNA ASPH to promote tumor
growth in lung adenocarcinoma. Cell Death Dis. 11:5932020.
View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Wang Y, Wo Y, Lu T, Sun X, Liu A, Dong Y,
Du W, Su W, Huang Z and Jiao W: Circ-AASDH functions as the
progression of early stage lung adenocarcinoma by targeting
miR-140-3p to activate E2F7 expression. Transl Lung Cancer Res.
10:57–70. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Du J, Zhang G, Qiu H, Yu H and Yuan W: The
novel circular RNA circ-CAMK2A enhances lung adenocarcinoma
metastasis by regulating the miR-615-5p/fibronectin 1 pathway. Cell
Mol Biol Lett. 24:722019. View Article : Google Scholar :
|
|
176
|
Gao N and Ye B: Circ-SOX4 drives the
tumorigenesis and development of lung adenocarcinoma via sponging
miR-1270 and modulating PLAGL2 to activate WNT signaling pathway.
Cancer Cell Int. 20:22020. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Shi J, Lv X, Zeng L, Li W, Zhong Y, Yuan
J, Deng S, Liu B, Yuan B, Chen Y, et al: CircPVT1 promotes
proliferation of lung squamous cell carcinoma by binding to
miR-30d/e. J Exp Clin Cancer Res. 40:1932021. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Wang L, Xu C, Wang C, Gong W, Zhang K,
Chen Q, Zhou S and Qi T: Circ-PAX2 promotes proliferation and
metastasis by absorbing miR-186 in lung cancer cells. Int J Clin
Exp Pathol. 11:3793–3801. 2018.PubMed/NCBI
|
|
179
|
Yu M, Tian Y, Wu M, Gao J, Wang Y, Liu F,
Sheng S, Huo S and Bai J: A comparison of mRNA and circRNA
expression between squamous cell carcinoma and adenocarcinoma of
the lungs. Genet Mol Biol. 43:e202000542020. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Huang W, Yang Y, Wu J, Niu Y, Yao Y, Zhang
J, Huang X, Liang S, Chen R, Chen S and Guo L: Circular RNA cESRP1
sensitises small cell lung cancer cells to chemotherapy by sponging
miR-93-5p to inhibit TGF-β signalling. Cell Death Differ.
27:1709–1727. 2020. View Article : Google Scholar
|
